Group B Streptococcus Antigens
Details for Australian Patent Application No. 2007202175 (hide)
International Classifications
Event Publications
31 May 2007 Complete Application Filed
7 June 2007 Application Open to Public Inspection
Published as AU-B-2007202175
15 July 2010 Application Accepted
Published as AU-B-2007202175
11 November 2010 Standard Patent Sealed
9 August 2012 Application for Amendment
The nature of the amendment is: Amend the patentee name to read ID Biomedical Corporation of Quebec . Address for service in Australia - Cullens Patent and Trade Mark Attorneys Level 32 239 George Street Brisbane QLD 4000
23 August 2012 Alteration of Name
The name of the patentee has been altered to ID Biomedical Corporation of Quebec
6 September 2012 Assignment Registered
ID Biomedical Corporation The patent has been assigned to ID Biomedical Corporation of Quebec Assignments Registered
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007202176-Cytotoxic T Lymphocytes Activated by Dendritic Cell Hybrids
2007202174-Facing material with controlled porosity for construction boards
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser